HARRISBURG – PA Attorney General Dave Sunday announced the state is part of a $720 million combined national settlement with eight drug manufacturers that worsened the opioid crisis. PA could receive up to $28 million, dependent on how many local governments participate in the proposed settlement. The eight companies are Mylan, Hikma, Amneal, Apotex, Indivior, Sun, Alvogen, and Zydus. Seven companies, not including Indivior, are prohibited from promoting or marketing opioids and opioid products, making or selling any product that contains more than 40 mg. of oxycodone per pill, and establishing a monitoring and reporting system for suspicious orders. Indivior has agreed to not manufacture or sell opioid products for the next 10 years, but it will be able to continue selling medications to treat opioid use disorder.
DAVID SUNDAY